There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

Multiple sclerosis, a complex neurological condition affecting nearly 3 million people worldwide, has long been characterized by its elusiveness. Even as medical imaging technology has advanced ...

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

For the first time, UCL researchers have used AI to identify two biologically distinct forms of multiple sclerosis ...

Researchers at University College London have developed a new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis ...

By analysing MRI scans and a simple blood test from hundreds of patients, researchers identified patterns that reveal how ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

The team, consisting of researchers from University College London (UCL) and Queen Square Analytics, analysed 634 patients ...

Two new sub-types of multiple sclerosis (MS) were discovered by researchers from Queen Square Analytics and University ...

The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...

Teriflunomide (Aubagio, Genzyme/Sanofi), a once-daily oral medication approved for relapsing-remitting multiple sclerosis (RRMS), significantly slows brain volume loss in these patients, a reanalysis ...